Aetion
高管
查看带有其 22 名主要高管的组织结构图
Aetion 搜索最多的简介
- Jeremy Rassen, Interim Chief Executive Officer
- Mohamad Makhzoumi, Director
- Tom Peterson, Board Member
高管在Aetion变化
- Jeremy Rassen 曾任 President and Board Director, 现升职为 Interim Chief Executive Officer (新闻发布的2024九月16号).
- Carolyn Magill, Chief Executive Officer and Board Director, 已经离开公司 (新闻发布的2024九月16号).
- Ken Watson 曾任 Senior Vice President of Engineering, 现升职为 Chief Technology Officer (新闻发布的2024六月25号).
创建提醒
跟踪 Aetion 的高管变动
医疗设备
Aetion 拥有 1,000 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。
Popular M&A news in 医疗设备
- Vitara Biomedical 刚刚宣布为 50 筹款数百万美元。 (公布2024十一月27号).
- Boston Scientific 已收购 Axonics Modulation Technologies (公布2024十一月18号).
- ShiraTronics 刚刚宣布为 66 筹款数百万美元。 (公布2024十月23号).
医疗设备 行业的其他推荐联系人
消息
Aetion 的最新新闻稿
- Aetion Announces Leadership Changes
- Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
- Aetion Launches Barcelona Technology Hub and Appoints Ken Watson as Chief Technology Officer
- Prophecy Enables Aetion to Quickly Deliver Critical Healthcare Data Analytics
- Aetion to Assess the Potential for Greater Inclusivity in Randomized Controlled Trials within the Field of Oncology - Aetion
- Aetion® Publishes Screening Tool to Identify Candidate Programs for Using Real-World Evidence to Support Effectiveness Claims in FDA Applications in Peer-Reviewed Journal - Aetion
- Aetion® Launches New Application for Descriptive Analytics and Fast, Reliable Insights - Aetion
- RCT-DUPLICATE Findings Demonstrate Capability of Real-World Evidence Studies to Reach Conclusions Similar to Randomized Clinical Trials - Aetion
- TREAT-NMD, a Leading Global NeuroMuscular Diseases Registry Network, and Aetion Announce Partnership on Real-World Evidence - Aetion
- Aetion Collaborates With FDA to Explore Oncology RWD for Regulatory Science Research - Aetion
- View more press releases Close
通过电子邮件
